clopenthixol has been researched along with flupenthixol in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (41.03) | 18.7374 |
1990's | 5 (12.82) | 18.2507 |
2000's | 10 (25.64) | 29.6817 |
2010's | 3 (7.69) | 24.3611 |
2020's | 5 (12.82) | 2.80 |
Authors | Studies |
---|---|
Gründig, E; Weiss, J | 1 |
Blake, B | 1 |
Kelly, PH; Miller, RJ | 1 |
Dahl, SG; Sylte, I | 1 |
Buckley, P; Cannon, M; Larkin, C | 1 |
Knudsen, P | 1 |
Beart, PM; Cincotta, M; de Vries, DJ | 1 |
Matheson, I; Skjaeraasen, J | 1 |
Dencker, SJ; Lepp, M; Malm, U | 3 |
Arnt, J | 1 |
Nielsen, IM | 1 |
Fritze, J | 1 |
Arnt, J; Hyttel, J | 1 |
Dencker, SJ; Frankenberg, K; Hansen, V; Malm, U | 1 |
Jrgensen, A; Overø, KF | 1 |
Dencker, SJ; Jørgensen, A; Malm, U; Overø, KF | 1 |
Kharazmi, A; Nielsen, H; Sørensen, AL | 1 |
Gerlach, J; Larsen, EB | 1 |
Bindl, A; Eberlein-König, B; Przybilla, B | 1 |
Beddall, A; Collins, P; Dasani, H; Ludlam, CA; Manson, LM; Shima, M; Stewart, AJ | 1 |
Al-Sughayir, MA | 1 |
Gatternig, R; Henning, G; Kollroser, M; Schober, C | 1 |
al-Tamimi, SA; Alwarthan, AA; Aly, FA | 1 |
Bellgrove, MA; Bradshaw, JL; Vance, A | 1 |
Jira, T; Menyes, U; Roth, U; Sokoliess, T | 1 |
Drobizhev, MIu; Kozyrev, VN; Kraeva, GK; Kubrakov, MA; Smulevich, AB | 1 |
Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
Bäumer, D; Ebert, D; Tebartz van Elst, L; Trimble, MR | 1 |
Bogerts, B; Gubka, U; Weisser, H; Witzel, JG | 1 |
Ilchef, R | 1 |
Abel, K | 1 |
Lam, D; Patten, SB; Pringsheim, T; Tano, DS | 1 |
Høiseth, G; Solhaug, V; Waade, RB | 1 |
Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
Osman, E; Yıldız, M | 1 |
Christensen, J; Dreier, JW; Liu, X; Munk-Olsen, T; Trabjerg, BB | 1 |
Ay, AM; Kenar, ANI; Mert, A; Unal, GA | 1 |
1 review(s) available for clopenthixol and flupenthixol
Article | Year |
---|---|
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
1 trial(s) available for clopenthixol and flupenthixol
Article | Year |
---|---|
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
37 other study(ies) available for clopenthixol and flupenthixol
Article | Year |
---|---|
[The influence of neuroleptic drugs on urinary excretion of non-protein nitrogen (author's transl)].
Topics: Amino Acids; Clopenthixol; Clozapine; Creatinine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Hydrogen-Ion Concentration; Ion Exchange Resins; Nitrogen; Procyclidine; Schizophrenia; Thioridazine; Tranquilizing Agents; Urea | 1976 |
Depot neuroleptics in a community mental health service.
Topics: Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Psychotic Disorders; Thioxanthenes | 1979 |
The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.
Topics: Adenylyl Cyclase Inhibitors; Animals; Apomorphine; Behavior, Animal; Chlorpromazine; Clopenthixol; Clozapine; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Flupenthixol; Male; Methamphetamine; Models, Biological; Oxotremorine; Parasympathomimetics; Pimozide; Rats; Scopolamine; Substantia Nigra; Thioridazine; Tranquilizing Agents | 1975 |
Molecular structure and dynamics of cis(Z)-and trans(E)-flupenthixol and clopenthixol.
Topics: Clopenthixol; Computer Simulation; Electrochemistry; Flupenthixol; Models, Molecular; Molecular Conformation; Molecular Structure; Stereoisomerism; Thermodynamics | 1991 |
Abuse of neuroleptic drugs.
Topics: Administration, Oral; Adult; Clopenthixol; Delayed-Action Preparations; Female; Flupenthixol; Humans; Injections, Intravenous; Male; Substance-Related Disorders | 1991 |
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines | 1985 |
Characteristics of D-1 dopamine receptors labelled by [3H]fluphenazine in homogenates of rat neostriatum.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Binding, Competitive; Clopenthixol; Corpus Striatum; Female; Fenoldopam; Flupenthixol; Fluphenazine; In Vitro Techniques; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1 | 1985 |
Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients.
Topics: Adult; Breast; Clopenthixol; Female; Flupenthixol; Humans; Hydrogen-Ion Concentration; Lactation; Milk, Human; Nortriptyline; Pregnancy; Psychotic Disorders; Puerperal Disorders; Thioxanthenes; Time Factors; Triglycerides | 1988 |
Schizophrenic relapse after drug withdrawal is predictable.
Topics: Adult; Aged; Clopenthixol; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Thioxanthenes | 1986 |
Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Benzamides; Benzazepines; Clopenthixol; Dopamine; Dose-Response Relationship, Drug; Ergolines; Flupenthixol; Hydroxydopamines; Hypothalamus; Male; Motor Activity; Oxidopamine; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Spiperone | 1985 |
Pharmacological vs. clinical physiognomy of neuroleptics, with special reference to their sedative and antipsychotic effects.
Topics: Animals; Behavior, Animal; Chlorpromazine; Chlorprothixene; Clopenthixol; Dogs; Drug Evaluation, Preclinical; Drug Tolerance; Flupenthixol; Fluphenazine; Haloperidol; Mice; Motor Activity; Perphenazine; Rats; Tranquilizing Agents | 1974 |
Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.
Topics: Ambulatory Care; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Follow-Up Studies; Humans; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Social Adjustment; Substance Withdrawal Syndrome; Time Factors | 1980 |
Can neuroleptics influence the function of the brain hemispheres asymmetrically?
Topics: Animals; Antipsychotic Agents; Brain; Carotid Arteries; Clopenthixol; Dystonia; Flupenthixol; Functional Laterality; Haloperidol; Injections, Intra-Arterial; Male; Posture; Rats; Rats, Inbred Strains; Reserpine; Stereoisomerism | 1984 |
Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Antipsychotic Agents; Appetite Depressants; Benzamides; Benzazepines; Catalepsy; Clopenthixol; Ergolines; Flupenthixol; Humans; Hydroxydopamines; Male; Oxidopamine; Pergolide; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Stereotyped Behavior | 1984 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Evaluation; Factor Analysis, Statistical; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
Topics: Ambulatory Care; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Half-Life; Humans; Injections, Intramuscular; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
Topics: Ambulatory Care; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Flupenthixol; Humans; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1980 |
Thioxanthenes inhibit multiplication of Leishmania major and its attachment to human monocytes in vitro.
Topics: Animals; Antiprotozoal Agents; Chlorprothixene; Clopenthixol; Flupenthixol; Humans; In Vitro Techniques; Leishmania tropica; Monocytes; Stereoisomerism; Thioxanthenes | 1993 |
Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Male; Middle Aged; Neurologic Examination; Perphenazine; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Sick Role | 1996 |
Phototoxic properties of neuroleptic drugs.
Topics: Antipsychotic Agents; Chlorpromazine; Chlorprothixene; Clopenthixol; Dermatitis, Phototoxic; Drug Eruptions; Erythrocytes; Flupenthixol; Fluphenazine; Hemolysis; Humans; Methotrimeprazine; Perazine; Perphenazine; Phenothiazines; Promazine; Promethazine; Radiation Dosage; Thiazines; Thioridazine; Thiothixene; Trifluoperazine; Triflupromazine; Ultraviolet Rays | 1997 |
Acquired haemophilia in recipients of depot thioxanthenes.
Topics: Adult; Aged; Antipsychotic Agents; Autoantibodies; Clopenthixol; Factor VIII; Female; Flupenthixol; Hemophilia A; Humans | 2000 |
Depot antipsychotics. Patient characteristics and prescribing pattern.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Utilization; Female; Flupenthixol; Fluphenazine; Haloperidol; Hospitals, University; Humans; Male; Middle Aged; Practice Patterns, Physicians'; Psychotic Disorders; Saudi Arabia; Surveys and Questionnaires | 2000 |
HPLC-ESI-MS/MS determination of zuclopenthixol in a fatal intoxication during psychiatric therapy.
Topics: Adult; Antipsychotic Agents; Bipolar Disorder; Chromatography, High Pressure Liquid; Clopenthixol; Fatal Outcome; Female; Flupenthixol; Forensic Medicine; Humans; Injections, Intramuscular; Spectrometry, Mass, Electrospray Ionization | 2001 |
Flow-injection chemiluminometric determination of some thioxanthene derivatives in pharmaceutical formulations and biological fluids using the [Ru(dipy)3(2+)]-Ce(IV) system.
Topics: Antipsychotic Agents; Cesium; Clopenthixol; Flow Injection Analysis; Flupenthixol; Luminescent Measurements; Organometallic Compounds; Oxidation-Reduction; Ruthenium Compounds; Thiothixene | 2001 |
Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention.
Topics: Adolescent; Affect; Antipsychotic Agents; Attention; Benzodiazepines; Clopenthixol; Diazepam; Female; Flupenthixol; Frontal Lobe; Humans; Male; Olanzapine; Parietal Lobe; Perceptual Disorders; Pirenzepine; Reaction Time; Risperidone; Schizophrenia; Space Perception; Time Factors | 2003 |
Separation of cis- and trans-isomers of thioxanthene and dibenz[b,e]oxepin derivatives on calixarene- and resorcinarene-bonded high-performance liquid chromatography stationary phases.
Topics: Calixarenes; Chlorprothixene; Chromatography, High Pressure Liquid; Clopenthixol; Dibenzoxepins; Doxepin; Flupenthixol; Hydrogen-Ion Concentration; Indicators and Reagents; Isomerism; Macromolecular Substances; Phenylalanine; Thioxanthenes | 2002 |
[Psychotropic drugs used in a psychiatric hospital (pharmaco-epidemiologic aspects)].
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Carbazoles; Chlorprothixene; Clopenthixol; Data Collection; Dopamine Antagonists; Female; Fluoxetine; Flupenthixol; Hospitals, Psychiatric; Humans; Male; Mental Disorders; Mianserin; Middle Aged; Mirtazapine; Monoamine Oxidase Inhibitors; Moscow; Nootropic Agents; Olanzapine; Pharmacoepidemiology; Phenothiazines; Psychotropic Drugs; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sulpiride | 2003 |
Chronic antidopaminergic medication might affect amygdala structure in patients with schizophrenia.
Topics: Amygdala; Antipsychotic Agents; Brain; Clopenthixol; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Factor Analysis, Statistical; Flupenthixol; Haloperidol; Hippocampus; Humans; Psychotic Disorders; Risperidone; Schizophrenia; Trifluoperazine | 2004 |
Antipsychotic polypharmacy in the emergency treatment of highly aggressive schizophrenic prisoners - a retrospective study.
Topics: Adult; Aggression; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Drug Therapy, Combination; Emergency Services, Psychiatric; Flupenthixol; Humans; Pilot Projects; Prisoners; Retrospective Studies; Schizophrenia, Paranoid; Treatment Outcome | 2008 |
PBS delisting.
Topics: Australia; Clopenthixol; Flupenthixol; Insurance, Pharmaceutical Services | 2011 |
RE: PBS delisting.
Topics: Clopenthixol; Flupenthixol; Insurance, Pharmaceutical Services | 2011 |
The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Canada; Chlorpromazine; Clopenthixol; Clozapine; Female; Flupenthixol; Humans; Loxapine; Male; Olanzapine; Pharmacoepidemiology; Schizophrenia | 2011 |
Impact of CYP2D6 on serum concentrations of flupentixol, haloperidol, perphenazine and zuclopenthixol.
Topics: Clopenthixol; Cytochrome P-450 CYP2D6; Flupenthixol; Genotype; Haloperidol; Humans; Perphenazine; Retrospective Studies | 2021 |
Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Topics: Adenosine Monophosphate; Adult; Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Chlorpromazine; Clopenthixol; Clozapine; Flupenthixol; Fluphenazine; Haloperidol; Humans; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Pimozide; Quetiapine Fumarate; Risperidone; Sulpiride; Trifluoperazine | 2022 |
Association of Maternal Antipsychotic Prescription During Pregnancy With Standardized Test Scores of Schoolchildren in Denmark.
Topics: Antipsychotic Agents; Child; Clopenthixol; Cohort Studies; Denmark; Female; Flupenthixol; Humans; Male; Methotrimeprazine; Olanzapine; Perphenazine; Pregnancy; Prescriptions; Quetiapine Fumarate | 2022 |
Potential benefits of combining two long-acting injectable antipsychotic: a retrospective study.
Topics: Antipsychotic Agents; Clopenthixol; Flupenthixol; Humans; Paliperidone Palmitate; Retrospective Studies | 2023 |